Fresenius outlines plans to expand extracorporeal care portfolio to hearts, lungs

Dialysis giant Fresenius Medical Care has laid out a new five-year strategy to further expand the reach of its business beyond kidney disease by offering a portfolio of intensive care support products for failing hearts, lungs and other organs.